---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043757"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:34:59.851364+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Evofem secures voting agreements for Aditxt merger; Aditxt completes $2.28M preferred investment

## Summary
- Evofem signed voting agreements with Series E-1 stockholders and convertible noteholders to vote in favor of merger with Aditxt subsidiary Adifem.
- Aditxt completed $2.28M final preferred investment (Series F-1), meeting $5M total commitment under A&R Merger Agreement since May 2024.
- Closing conditions require majority stockholder vote and Aditxt raising ~$17M, including ~$15.2M to satisfy Evofem's senior secured noteholder.
- If Aditxt fails to secure funds, senior secured noteholder expected to block closing; no assurance conditions will be met.

## SEC filing metadata
- accession: 0001493152-24-043757
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315224043757/0001493152-24-043757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315224043757/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043757
- JSON: https://secwatch.observer/filing/0001493152-24-043757.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.